Observational studyHuman vaccines & immunotherapeutics2020

Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months-55 years.

Byung Wook Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.